Ignite Creation Date:
2024-05-06 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03603847
Status:
COMPLETED
Last Update Posted:
2023-09-26
First Post:
2018-07-18
Brief Title:
Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma
Sponsor:
The Lymphoma Academic Research Organisation
Organization:
The Lymphoma Academic Research Organisation
Organization Data
Organization:
The Lymphoma Academic Research Organisation
Class:
OTHER
Study ID:
ALK-OBS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Lymphoma Academic Research Organisation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Takeda | INDUSTRY |
| Hôpital Necker-Enfants Malades | OTHER |
| Fondation ARC | OTHER |
| Pfizer | INDUSTRY |